Found 11 matching trials
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
PHASE4Multi-center, non-randomized, open-label, single-dose, parallel group study...
Location
Hôpital Maisonneuve-Rosemont
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
PHASE4Randomized, single-dose, double-blind, placebo and active controlled, four-...
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
PHASE4Multi-center, non-randomized, open-label, single-dose, parallel group study...
Location
University of Miami
A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers
PHASE1Single center, randomized, double-blind, placebo-controlled, adaptive seque...
Location
Algorithme Pharma Inc.
Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects
PHASE1The purpose of this study was to examine the safety, efficacy, and pharmaco...
Location
PAREXEL International
Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
PHASE2The effect oral iron chelator Deferiprone on the Oxidative stress and on Ir...
Location
Chim Sheba Medical Center
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
PHASE2Systematical (retro- and prospective) investigation of the long-term safety...
Location
Cantonal Hospital, Children's Clinic
Active Drug Surveillance Program of Ferriprox Use
N/AObservational, open label, prospective, multi-center, post-marketing drug s...
Location
Thalassemia Center of North Cyprus Turkish Republic (KKTC)
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
PHASE3Comparison of efficacy and toxicity of the combination treatment of deferip...
Location
Pediatric Hospital, Cairo University
Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
PHASE3A multi-center, placebo controlled, double-blind trial comparing the effica...
Location
Children's Hospital & Research Center at Oakland